Regenerex Pharma (RGPX) Operating Expenses (2010 - 2025)
Regenerex Pharma (RGPX) reported Operating Expenses of $786709.0 for Q3 2025, up 204.47% year-over-year from $258384.0 in Q3 2024, and up 24.13% on a QoQ basis from $633783.0 in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Operating Expenses data on file, last reported at $786709.0 in Q3 2025.
- Quarterly Operating Expenses rose 204.47% year-over-year to $786709.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.7 million (up 164.81% YoY) and the FY2025 annual result came in at $1.8 million, down 47.31% from the prior year.
- Operating Expenses advanced to $786709.0 in Q3 2025 per RGPX's latest filing, from $633783.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $2.8 million in Q3 2023 and bottomed at $11688.0 in Q2 2021.
- The 5-year median for Operating Expenses is $199779.0 (2023), against an average of $385269.5.
- The widest annual swing landed in 2023, when Operating Expenses jumped 12855.37%; it then plunged 90.73% in 2024.
- Tracing RGPX's Operating Expenses over 5 years: stood at $61975.0 in 2021, then plunged by 53.04% to $29102.0 in 2022, then jumped by 722.57% to $239384.0 in 2023, then soared by 30.13% to $311510.0 in 2024, then surged by 152.55% to $786709.0 in 2025.
- Per Business Quant, the three latest RGPX Operating Expenses figures stand at $786709.0 (Q3 2025), $633783.0 (Q2 2025), and $1.0 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 786,709.00 |
| Jun 30, 2025 | 633,783.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 311,510.00 |
| Sep 30, 2024 | 258,384.00 |
| Jun 30, 2024 | 254,280.00 |
| Mar 31, 2024 | 280,344.00 |
| Dec 31, 2023 | 239,384.00 |
| Sep 30, 2023 | 2.79 Mn |
| Jun 30, 2023 | 160,174.00 |
| Mar 31, 2023 | 28,279.00 |
| Dec 31, 2022 | 29,102.00 |
| Sep 30, 2022 | 21,504.00 |
| Jun 30, 2022 | 17,285.00 |
| Mar 31, 2022 | 31,530.00 |
| Dec 31, 2021 | 61,975.00 |
| Sep 30, 2021 | 21,073.00 |
| Jun 30, 2021 | 11,688.00 |
| Dec 31, 2020 | 14,069.00 |
| Sep 30, 2020 | 12,043.00 |
| Jun 30, 2020 | 10,171.00 |
| Mar 31, 2020 | 21,051.00 |
| Dec 31, 2019 | 14,105.00 |
| Sep 30, 2019 | 11,622.00 |
| Jun 30, 2019 | 31,122.00 |
| Mar 31, 2019 | 16,055.00 |
| Dec 31, 2018 | 52,290.00 |
| Sep 30, 2018 | 4,820.00 |
| Jun 30, 2018 | 18,569.00 |
| Mar 31, 2018 | 13,950.00 |
| Dec 31, 2017 | 10,254.00 |
| Sep 30, 2017 | 8,144.00 |
| Jun 30, 2017 | 17,103.00 |
| Mar 31, 2017 | 8,144.00 |
| Nov 30, 2014 | -388,325.00 |
| Aug 31, 2014 | 9,436.00 |
| May 31, 2014 | 8,308.00 |
| Feb 28, 2014 | 3,070.00 |
| Nov 30, 2013 | -707,831.00 |
| Aug 31, 2013 | 245,932.00 |
| May 31, 2013 | 6,605.00 |
| Feb 28, 2013 | 244,573.00 |
| Nov 30, 2012 | 492,546.00 |
| Aug 31, 2012 | 10,745.00 |
| May 31, 2012 | 1,122.00 |
| Feb 29, 2012 | 142,936.00 |
| Nov 30, 2011 | 184,745.00 |
| Aug 31, 2011 | 16,048.00 |
| Nov 30, 2010 | 6,239.00 |
| Aug 31, 2010 | 17,843.00 |